Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
<i>Mycobacterium tuberculosis</i> (<i>M. tb</i>) is the etiological agent that is responsible for causing tuberculosis (TB). Although every year <i>M. tb</i> infection affects millions of people worldwide, the only vaccine that is currently available is the Bacill...
Main Authors: | Rachel Abrahem, Ruoqiong Cao, Brittanie Robinson, Shalok Munjal, Thomas Cho, Kimberly To, David Ashley, Joshua Hernandez, Timothy Nguyen, Garrett Teskey, Vishwanath Venketaraman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/10/1556 |
Similar Items
-
Determinants of Bacille Calmette-Guérin scarification in Danish children
by: Trine Mølbæk Jensen, et al.
Published: (2021-01-01) -
When the Treatment is the Cause: Disseminated Bacille Calmette–Guérin Infection
by: Ana Teresa Marques Afonso, et al.
Published: (2020-06-01) -
Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
by: Anadi Roy Chowdhury, et al.
Published: (2013-01-01) -
Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report
by: Octavio Castillo Cádiz, et al.
Published: (2016-06-01) -
Bacille Calmette–Guérin (BCG) Vaccine Induced Tuberculous Lymphadenitis: A Case Report
by: Kalyan Sapkota
Published: (2020-12-01)